Astrana Health (ASTH) Projected to Post Earnings on Thursday

Astrana Health (NASDAQ:ASTH) is expected to be releasing its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Astrana Health to post earnings of $0.29 per share and revenue of $949.2070 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:30 PM ET.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Monday, March 2nd. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The firm had revenue of $950.53 million during the quarter, compared to analysts’ expectations of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The business’s quarterly revenue was up 42.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.15) earnings per share. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Stock Up 0.6%

Shares of ASTH stock traded up $0.21 during trading on Tuesday, reaching $35.19. The company’s stock had a trading volume of 519,192 shares, compared to its average volume of 514,118. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.40 and a quick ratio of 1.40. The company has a market capitalization of $1.96 billion, a price-to-earnings ratio of 76.50 and a beta of 0.98. The stock’s 50-day moving average price is $26.43 and its 200 day moving average price is $25.58. Astrana Health has a 1-year low of $18.08 and a 1-year high of $35.85.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Tower Research Capital LLC TRC boosted its holdings in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares in the last quarter. State of Wyoming acquired a new position in shares of Astrana Health in the 2nd quarter valued at $132,000. Los Angeles Capital Management LLC acquired a new position in shares of Astrana Health in the 4th quarter valued at $228,000. WINTON GROUP Ltd acquired a new position in shares of Astrana Health in the 2nd quarter valued at $233,000. Finally, Vestcor Inc boosted its holdings in shares of Astrana Health by 180.8% in the 3rd quarter. Vestcor Inc now owns 10,385 shares of the company’s stock valued at $294,000 after buying an additional 6,687 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ASTH. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. Robert W. Baird boosted their price target on shares of Astrana Health from $37.00 to $40.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Truist Financial boosted their price target on shares of Astrana Health from $37.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, March 13th. Weiss Ratings upgraded shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, BTIG Research lowered their price target on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a report on Monday, February 2nd. Six research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Astrana Health presently has a consensus rating of “Moderate Buy” and an average price target of $34.86.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.